Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Cord Blood Transplantation Is an Effective Treatment Option in Patients with Myelodysplastic and Myeloproliferative Syndromes

Laura Roberts, Rachel B. Salit, MD, Lauren Longo, Elisabetta Xue, MD, Corinne Summers, MD, Colleen Delaney, MD MSc, Ann Dahlberg, MD, Filippo Milano, MD PhD

Blood (2019) 134 (Supplement_1): 2048.

https://doi.org/10.1182/blood-2019-126216

Published: 2019

Journal Articles

No Engraftment Advantage after Single or Double Umbilical Cord Blood Transplant (CBT) with the Addition of a Non-HLA Matched Off-the-Shelf Expanded Cord Blood Unit Compared to Conventional CBT: Results of a Randomized Trial

Filippo Milano, MD PhD, Andrew R Rezvani, MD, Joanne Kurtzberg, MD, Chatchada Karanes, MD, Jonathan A Gutman, MD, Christine Duncan, MD, Alla Keyzner, MD, Rabi Hanna, MD, Tonya Kimberly Marmon, PhD, Ann Dahlberg, MD, Colleen Delaney, MD MSc

Blood (2019) 134 (Supplement_1): 146.

https://doi.org/10.1182/blood-2019-130716

Published: 2019

Journal Articles

High Incidence of Herpes Zoster after Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral Prophylaxis

Elisabetta Xue, MD, Hu Xie, Wendy Leisenring, ScD, Louise E Kimball, PhD RN, Sonia Goyal, Lisa Chung, Rachel Blazevic, Byron Maltez, Ann Dahlberg, MD, Rachel B. Salit, MD, Colleen Delaney, MD MSc, Steven A. Pergam, MDMPH, Michael Boeckh, MD, Filippo Milano, MD PhD, Joshua Aiden Hill, MD

Blood (2019) 134 (Supplement_1): 4556.

https://doi.org/10.1182/blood-2019-124211

Published: 2019

Journal Articles

Retrospective Evaluation of the Use of Romiplostim after Hematopoietic Stem Cell Transplantation0

Elisabetta Xue, MD, Tatiana Lawrence, MD, Terry B. Gernsheimer, MD, Filippo Milano, MD PhD

Blood (2019) 134 (Supplement_1): 5660.

https://doi.org/10.1182/blood-2019-128673

Published: 2019

Journal Articles

Demonstration of the Safety of Post Induction Infusion of Ex-Vivo Expanded Cord Blood Progenitor Cells in Pediatric Patients with Relapsed/Refractory Acute Myelogenous Leukemia

Ann Dahlberg, MD, Muna Qayed, MDMSc, Katherine Tarlock, MD, Jessica A. Pollard, MD, Filippo Milano, MD PhD, Soheil Meshinchi, MD PhD, Colleen Delaney, MD MSc

Blood (2019) 134 (Supplement_1): 2614.

https://doi.org/10.1182/blood-2019-130979

Published: 2019

Journal Articles

UM171 Modified Cord Blood Achieves Excellent Survival and Disease Control after 2 Years of Follow-up in High and Very High Risk Malignancies

Sandra Cohen, MD FRCP(C), Jean Roy, MD, Jean-Sébastien Delisle, MD PhD, Nadia M. Bambace, MD, Imran Ahmad, MD, Silvy Lachance, MD FRCP, Léa Bernard, MD, Frederic Barabe, MD, Thomas L. Kiss, MD, Lambert Busque, MD, Denis-Claude Roy, MD, Filippo Milano, MD PhD, Guy Sauvageau, MD PhD

Blood (2019) 134 (Supplement_1): 3245.

https://doi.org/10.1182/blood-2019-121698

Published: 2019

Journal Articles

Comparison of Outcomes between HSCT Donor Sources for Pediatric Patients with Hematologic Malignancies

Lauren Longo, Filippo Milano, MD PhD, Colleen Delaney, MD MSc, Marie Bleakley, MBBS, PhD MMSc, Lauri S Burroughs, MD, Brandon Hadland, MD PhD, Elisabetta Xue, MD, Laura Roberts, Soheil Meshinchi, MD PhD, Kanwaldeep K. Mallhi, MD, Monica Thakar, MD, K Scott Baker, MD MS, Corinne Summers, MD, Ann Dahlberg, MD

Blood (2019) 134 (Supplement_1): 4611.

https://doi.org/10.1182/blood-2019-126062

Published: 2019

Journal Articles

Comparison of Chronic Graft-Versus-Host Disease Severity and Functional Status after Cord Blood, Haploidentical Related and 1-Allele Mismatched Unrelated Donor Hematopoietic Cell Transplantation

Giancarlo Fatobene, MD, Barry E. Storer, PhD, Rachel B. Salit, MD, Stephanie J. Lee, MD PhD, Paul J. Martin, MD, Guang-Shing Cheng, MD, Colleen Delaney, MD, Frederick R. Appelbaum, MD, Brenda M. Sandmaier, MD, Filippo Milano, MD PhD, Mary E. Flowers, MD

Blood (2017) 130 (Supplement 1): 73.

https://doi.org/10.1182/blood.V130.Suppl_1.73.73

Published: 2017

Journal Articles

Infusion of Ex-Vivo Expanded Cord Blood Progenitor Cells Reduces the Time to Platelet Engraftment and the Number of Platelet and Red Blood Cell Transfusions Required in Patients Receiving Myleloblative Cord Blood Transplants

Emily R Cox, Qian Vicky Wu, Rachel Salit, MD, Colleen Delaney, MD MSc, Filippo Milano, MD PhD

Blood (2016) 128 (22): 1232.

https://doi.org/10.1182/blood.V128.22.1232.1232

Published: 2016

Journal Articles

Myeloablative Cord Blood Transplantation Yields Excellent Disease Free Survival in Patients with Acute Lymphoblastic Leukemia

David Charles Keahi Oliver, BS, Ryan D Cassaday, MD, Ralph P Ermoian, MD, Ann Dahlberg, MD, Colleen Delaney, MD MSc, Filippo Milano, MD PhD

Blood (2016) 128 (22): 4693.

https://doi.org/10.1182/blood.V128.22.4693.4693

Published: 2016

Journal Articles

Detection of Multiple Double-Stranded DNA Viruses after Cord Blood Transplantation Is Frequent and Persistent

Joshua A Hill, MD, Bryan T Mayer, PhD, Hu Xie, MSc, Wendy M Leisenring, PhD, Filippo Milano, MD PhD, Colleen Delaney, MD MSc, Meei-Li Huang, PhD, Terry L Stevens-Ayers, MS, Keith R Jerome, MD PhD, Garrett Nichols, MD MS, Danielle M Zerr, MD MPH, Joshua T Schiffer, MD MS, Michael Boeckh, MD

Blood (2015) 126 (23): 3104.

https://doi.org/10.1182/blood.V126.23.3104.3104

Published: 2015

Journal Articles

Distinct Patterns of Early Hematopoietic Reconstitution in Patients Receiving Notch Expanded Non HLA-Matched Off-the-Shelf Cord Blood Derived Hematopoietic Stem and Progenitor Cells

Jianqiang Li, PhD MSc, Allen Jiang, Filippo Milano, MD PhD, Suzan Imren, MD, David Charles Keahi Oliver, BS, Joseph Blake, Colleen Delaney, MD MSc

Blood (2015) 126 (23): 379.

https://doi.org/10.1182/blood.V126.23.379.379

Published: 2015

Journal Articles

Better High Resolution HLA-Matching Is Associated with Lower Transplant Related Mortality after Cord Blood Transplantation

Paige Albert, Colleen Delaney, MD MSc, Rachel Salit, MD, Nancy Anderson, Filippo Milano, MD PhD

Blood (2015) 126 (23): 4405.

https://doi.org/10.1182/blood.V126.23.4405.4405

Published: 2015

Journal Articles

Persistence of the Losing Unit Following Double Umbilical Cord Blood Transplant: Finding the Unseen

David Charles Keahi Oliver, BS, Filippo Milano, MD PhD, Hilary Gammill, MD, Coline Gentil, MS, Sami B. Kanaan, PhD, Judy Allen, MPH, Lee Nelson, MD, Colleen Delaney, MD MSc

Blood (2015) 126 (23): 3109.

https://doi.org/10.1182/blood.V126.23.3109.3109

Published: 2015

Journal Articles

Second Allogeneic Transplant with Cord Blood for Treatment of Failed First Allogeneic Transplant Due to Primary Graft Failure or Disease Recurrence

Rachel B. Salit, MD, Filippo Milano, MD PhD, Ivy B. Riffkin, David C. Oliver, Nancy L. Anderson, Colleen Delaney, MD MSC

Blood (2014) 124 (21): 3940.

https://doi.org/10.1182/blood.V124.21.3940.3940

Published: 2014

Journal Articles

Real-Time Immunophenotyping of Peripheral Blood Early Post Myeloablative Cord Blood Transplant Can Identify Patients at Risk for Primary Graft Failure

Jianqiang Li, PhD, Filippo Milano, MD PhD, Joseph M Blake, David C. Oliver, Ian Nicoud, PhD, Shelly Heimfeld, PhD, Colleen Delaney, MD

Blood (2014) 124 (21): 3897.

https://doi.org/10.1182/blood.V124.21.3897.3897

Published: 2014

Journal Articles

Infusion of Ex Vivo Expanded Cord Blood Progenitor Cells Reduces the Risk of Bacteremia after Myeloablative Cord Blood Transplant

Corinne Summers, MD, Filippo Milano, MD PhD, Ted A. Gooley, PhD, Ann Dahlberg, MD, Colleen Delaney, MD MSC

Blood (2014) 124 (21): 3860.

https://doi.org/10.1182/blood.V124.21.3860.3860

Published: 2014

Journal Articles

Infusion of a Non HLA-Matched Off-the-Shelf Ex Vivo Expanded Cord Blood Progenitor Cell Product Following Myeloablative Cord Blood Transplantation Is Safe, Decreases the Time to Hematopoietic Recovery, and Results in Excellent Overall Survival

Filippo Milano, MD PhD, Shelly Heimfeld, PhD, Ivy B. Riffkin, Ian Nicoud, PhD, Frederick R. Appelbaum, MD, Irwin D. Bernstein, MD, Colleen Delaney, MD

Blood (2014) 124 (21): 46.

https://doi.org/10.1182/blood.V124.21.46.46

Published: 2014

Journal Articles

Notch-Expanded Murine Hematopoietic Progenitor Cells Can Induce Immune Tolerance in Mismatched Recipients

Fabiola V Merriam, PhD, Ian Nicoud, PhD, Filippo Milano, MD PhD, Jianqiang Li, PhD, Shelly Heimfeld, PhD, Colleen Delaney, MD

Blood (2014) 124 (21): 2430.

https://doi.org/10.1182/blood.V124.21.2430.2430

Published: 2014

Journal Articles

Comorbidity Index in the Context of Cord Blood Transplantation: An Accurate Predictor of Treatment Related Mortality?

David C. Oliver, Filippo Milano, MD PhD, Colleen Delaney, MD MSC, Mohamed L. Sorror, MD MSc, Rachel B. Salit, MD

Blood (2014) 124 (21): 1205.

https://doi.org/10.1182/blood.V124.21.1205.1205

Published: 2014

NARROW

Cord Blood Transplantation Is an Effective Treatment Option in Patients with Myelodysplastic and Myeloproliferative Syndromes

No Engraftment Advantage after Single or Double Umbilical Cord Blood Transplant (CBT) with the Addition of a Non-HLA Matched Off-the-Shelf Expanded Cord Blood Unit Compared to Conventional CBT: Results of a Randomized Trial

High Incidence of Herpes Zoster after Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral Prophylaxis

Retrospective Evaluation of the Use of Romiplostim after Hematopoietic Stem Cell Transplantation0

Demonstration of the Safety of Post Induction Infusion of Ex-Vivo Expanded Cord Blood Progenitor Cells in Pediatric Patients with Relapsed/Refractory Acute Myelogenous Leukemia

UM171 Modified Cord Blood Achieves Excellent Survival and Disease Control after 2 Years of Follow-up in High and Very High Risk Malignancies

Comparison of Outcomes between HSCT Donor Sources for Pediatric Patients with Hematologic Malignancies

Comparison of Chronic Graft-Versus-Host Disease Severity and Functional Status after Cord Blood, Haploidentical Related and 1-Allele Mismatched Unrelated Donor Hematopoietic Cell Transplantation

Infusion of Ex-Vivo Expanded Cord Blood Progenitor Cells Reduces the Time to Platelet Engraftment and the Number of Platelet and Red Blood Cell Transfusions Required in Patients Receiving Myleloblative Cord Blood Transplants

Myeloablative Cord Blood Transplantation Yields Excellent Disease Free Survival in Patients with Acute Lymphoblastic Leukemia

Detection of Multiple Double-Stranded DNA Viruses after Cord Blood Transplantation Is Frequent and Persistent

Distinct Patterns of Early Hematopoietic Reconstitution in Patients Receiving Notch Expanded Non HLA-Matched Off-the-Shelf Cord Blood Derived Hematopoietic Stem and Progenitor Cells

Better High Resolution HLA-Matching Is Associated with Lower Transplant Related Mortality after Cord Blood Transplantation

Persistence of the Losing Unit Following Double Umbilical Cord Blood Transplant: Finding the Unseen

Second Allogeneic Transplant with Cord Blood for Treatment of Failed First Allogeneic Transplant Due to Primary Graft Failure or Disease Recurrence

Real-Time Immunophenotyping of Peripheral Blood Early Post Myeloablative Cord Blood Transplant Can Identify Patients at Risk for Primary Graft Failure

Infusion of Ex Vivo Expanded Cord Blood Progenitor Cells Reduces the Risk of Bacteremia after Myeloablative Cord Blood Transplant

Infusion of a Non HLA-Matched Off-the-Shelf Ex Vivo Expanded Cord Blood Progenitor Cell Product Following Myeloablative Cord Blood Transplantation Is Safe, Decreases the Time to Hematopoietic Recovery, and Results in Excellent Overall Survival

Notch-Expanded Murine Hematopoietic Progenitor Cells Can Induce Immune Tolerance in Mismatched Recipients

Comorbidity Index in the Context of Cord Blood Transplantation: An Accurate Predictor of Treatment Related Mortality?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only